Yeojin Boo

Yeojin Boo

Auto-generated profile, based on publicly available information

Yeojin Boo

Department of Surgery, Ajou University School of Medicine, Suwon, Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
YBYeojin Boo
Yeojin Boo
HSHo-Jung Shin
Ho-Jung Shin
JSJeong Ho Song
Jeong Ho Song
SSSang-Yong Son
Sang-Yong Son
HHHoon Hur
Hoon Hur
SHSang-Uk Han
Sang-Uk Han
Boo Y, et al. J Gastric Cancer. 2025 Jul;25:e38. https://doi.org/10.5230/jgc.2025.25.e38

31 January 2023 in Kidney Research and Clinical Practice
Verified
Journal Article
Open access
PDF file
YBYeojin Boo
Yeojin Boo
HYHyunee Yim
Hyunee Yim
JBJun Bae Bang
Jun Bae Bang

25 June 2025 in Vascular Specialist International
Verified
Journal Article
Open access
PDF file
YBYeo-Jin Boo
Yeo-Jin Boo
SHSang-Uk Han
Sang-Uk Han
HHHoon Hur
Hoon Hur
JBJun Bae Bang
Jun Bae Bang
Yeo-Jin Boo, Sang-Uk Han, Hoon Hur, and Jun Bae Bang. Vasc Specialist Int 2025;41:. https://doi.org/10.5758/vsi.250017

1 January 2026 in Journal of Gastric Cancer
Verified
Journal Article
Open access
PDF file
JSJeong Ho Song
Jeong Ho Song
SWSeoYeon Wi
SeoYeon Wi
YBYeojin Boo
Yeojin Boo
SPSung Hyun Park
Sung Hyun Park
MCMinah Cho
Minah Cho
HKHyoungil Kim
Hyoungil Kim
Song JH, et al. J Gastric Cancer. 2026 ;26:e44. https://doi.org/10.5230/jgc.2026.26.e44

1 January 2026 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
MKMee Rae Kim
Mee Rae Kim
YLYubin Lee
Yubin Lee
YBYeojin Boo
Yeojin Boo
JSJeong Ho Song
Jeong Ho Song
SSSang-Yong Son
Sang-Yong Son
SHSang-Uk Han
Sang-Uk Han
This study aimed to evaluate surgical outcomes, identify complications, and analyze recurrence in patients undergoing surgery for primary retroperitoneal tumors (RPTs), which pose significant therapeutic challenges. We retrospectively reviewed the medical records of 59 patients who underwent surgery for primary RPTs at Ajou University Hospital between January 2015 and December 2024. Patients were divided into a multivisceral resection (MVR) group (n = 25) and a non-MVR group (n = 34) to compare demographics, clinical characteristics, pathological findings, and postoperative outcomes. Compared to the non-MVR group, the MVR group had a significantly higher rate of open surgery (96.0% vs. 73.5%, P = 0.034), longer operative times (237.6 minutes vs. 188.8 minutes, P = 0.032), more frequent R2 resections (32.0% vs. 8.8%, P = 0.018), and longer hospital stays (13.1 days vs. 7.0 days, P = 0.007). Malignant tumors comprised 67.7% of cases, with sarcoma being the most common. Recurrence rates were highest in well-differentiated liposarcoma (50.0%) and dedifferentiated liposarcoma (22.2%). While univariate analysis showed MVR was associated with severe morbidity (Clavien-Dindo grade ≥III; odds ratio, 6.200; P = 0.029), this was not sustained as an independent predictor in multivariable analysis. Although MVR was associated with severe complications in univariate analysis, it was not an independent predictor in multivariable analysis. This suggests the increased risk reflects overall surgical complexity. Therefore, MVR should be pursued when oncologically necessary, as it presents an acceptable morbidity profile.

1 January 2026 in Journal of Metabolic and Bariatric Surgery
Verified
Journal Article
Open access
SSSang-Yong Son
Sang-Yong Son
YBYeo-Jin Boo
Yeo-Jin Boo
JSJeong Ho Song
Jeong Ho Song
HHHoon Hur
Hoon Hur
SHSang-Uk Han
Sang-Uk Han
Sleeve gastrectomy with proximal jejunal bypass (SG-PJB) is a simplified sleeve-plus procedure designed to augment the metabolic impact of sleeve gastrectomy while avoiding the long-term complications associated with Roux-en-Y gastric bypass (RYGB). Early studies demonstrate that SG-PJB achieves diabetes remission and metabolic improvements comparable to RYGB, with sustained insulin independence in previously insulin-dependent patients. The procedure preserves duodenal continuity and maintains physiologic nutrient absorption, and no cases of hypoalbuminemia or bacterial overgrowth have been reported. Despite its promising balance of metabolic efficacy and nutritional safety, further research is required to clarify optimal indications, determine appropriate bypass limb lengths, and validate long-term safety. As current data suggest, SG-PJB offers a favorable risk–benefit profile and may become a valuable alternative within the sleeve-plus spectrum.